These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9610785)
1. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785 [TBL] [Abstract][Full Text] [Related]
2. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594 [TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898 [TBL] [Abstract][Full Text] [Related]
4. NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Millikan RC Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):217-9. PubMed ID: 10698485 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321 [TBL] [Abstract][Full Text] [Related]
6. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074 [TBL] [Abstract][Full Text] [Related]
7. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806 [TBL] [Abstract][Full Text] [Related]
8. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking. Okkels H; Sigsgaard T; Wolf H; Autrup H Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426 [TBL] [Abstract][Full Text] [Related]
9. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012 [TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632 [TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392 [TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population. Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396 [TBL] [Abstract][Full Text] [Related]
14. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls. Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770 [TBL] [Abstract][Full Text] [Related]
15. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Terry PD; Goodman M Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):602-11. PubMed ID: 16614098 [TBL] [Abstract][Full Text] [Related]
16. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study. Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951 [TBL] [Abstract][Full Text] [Related]
17. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors. Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556 [TBL] [Abstract][Full Text] [Related]
18. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Slattery ML; Potter JD; Samowitz W; Bigler J; Caan B; Leppert M Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1079-84. PubMed ID: 9865425 [TBL] [Abstract][Full Text] [Related]
19. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cascorbi I; Roots I; Brockmöller J Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]